UA104030U - Method for treating patients with acute condition of chronic bronchitis of viral etiology - Google Patents

Method for treating patients with acute condition of chronic bronchitis of viral etiology

Info

Publication number
UA104030U
UA104030U UAU201506500U UAU201506500U UA104030U UA 104030 U UA104030 U UA 104030U UA U201506500 U UAU201506500 U UA U201506500U UA U201506500 U UAU201506500 U UA U201506500U UA 104030 U UA104030 U UA 104030U
Authority
UA
Ukraine
Prior art keywords
chronic bronchitis
acute condition
treating patients
viral etiology
viral
Prior art date
Application number
UAU201506500U
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Олександр Ярославович Дзюблик
Микола Іванович Гуменюк
Ніна Миколаївна Недлінська
Георгій Борисович Капітан
Віталій Анатолійович Ячник
Ростислав Євгенович Сухін
Олександр Олександрович Мухін
Ольга Василівна Денисова
Original Assignee
Державна Установа "Національний Інститут Фтизіатрії І Пульмонології Ім. Ф.Г. Яновського Національної Академії Медичних Наук України"
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Державна Установа "Національний Інститут Фтизіатрії І Пульмонології Ім. Ф.Г. Яновського Національної Академії Медичних Наук України" filed Critical Державна Установа "Національний Інститут Фтизіатрії І Пульмонології Ім. Ф.Г. Яновського Національної Академії Медичних Наук України"
Priority to UAU201506500U priority Critical patent/UA104030U/en
Publication of UA104030U publication Critical patent/UA104030U/en

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The method for treating the patients with the acute condition of the chronic bronchitis of viral etiology comprises the use of Decametoxin as antiseptic and mucolytic. Furthermore, L-arginine aspartate is used at the pharmacopeian acceptable dose and mode of administration.
UAU201506500U 2015-07-02 2015-07-02 Method for treating patients with acute condition of chronic bronchitis of viral etiology UA104030U (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UAU201506500U UA104030U (en) 2015-07-02 2015-07-02 Method for treating patients with acute condition of chronic bronchitis of viral etiology

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UAU201506500U UA104030U (en) 2015-07-02 2015-07-02 Method for treating patients with acute condition of chronic bronchitis of viral etiology

Publications (1)

Publication Number Publication Date
UA104030U true UA104030U (en) 2016-01-12

Family

ID=55362508

Family Applications (1)

Application Number Title Priority Date Filing Date
UAU201506500U UA104030U (en) 2015-07-02 2015-07-02 Method for treating patients with acute condition of chronic bronchitis of viral etiology

Country Status (1)

Country Link
UA (1) UA104030U (en)

Similar Documents

Publication Publication Date Title
SG10201901010PA (en) Combination therapy for treating a paramyxovirus
CA2909335C (en) Fenfluramine for use in the treatment of dravet syndrome
MX2021000289A (en) Methods for treating high cardiovascular risk patients with hypercholesterolemia.
MX2016010504A (en) Methods for treating patients with hypercholesterolemia that is not adequately controlled by moderate-dose statin therapy.
MX365939B (en) Nuclear transport modulators and uses thereof.
MX2022007221A (en) Valproic acid for the treatment or prevention of pathological conditions associated with excess fibrin deposition and/or thrombus formation.
MX2018006674A (en) Cancer treatment using 2-deoxy-2-fluoro-l-fucose in combination with a checkpoint inhibitor.
MX2016015434A (en) Pharmaceutical combinations for treating cancer.
PH12017500933A1 (en) Sublingual administration of riluzole
EA201491699A1 (en) CANCER TREATMENT WITH TOR KINASE INHIBITORS
PH12016502352A1 (en) Pharmaceutical composition
WO2019040106A3 (en) Compounds, salts thereof and their use in the treatment of diseases
BR112017026061A2 (en) compound, use of a compound, and method of treating a viral infection
TW201613578A (en) Pharmaceutical combinations
PH12017500934A1 (en) Sublingual formulation of riluzole
PH12016501751A1 (en) Pyridazine derivatives for use in the prevention or treatment of an ataxic disorder
MX2017016096A (en) Blood pressure-lowering agent.
MX2018010223A (en) Combination therapy for treatment of ovarian cancer.
MX2021014120A (en) Treatment of androgen deprivation therapy associated symptoms.
MX2017009313A (en) Intravenous baclofen formulations and treatment methods.
UA104030U (en) Method for treating patients with acute condition of chronic bronchitis of viral etiology
MX2018004656A (en) Intravenous baclofen and methods of treatment.
CL2015001705A1 (en) Use of pidotimod to treat psoriasis
UA103888U (en) Phenol solution for injection for treatment of chronic pain syndrome
UA88138U (en) Dosage form for treatment and prevention of tissue ischemia in form of oral solution